We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Phillips, SJ.Pathophysiology and management of hypertension in acute ischemic stroke. Hypertension1994;23(i):131–136.CrossRefGoogle ScholarPubMed
2
2.Leonardi-Bee, J, Bath, PMW, Phillips, SJ, Sandercock, PAG, for the IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke2002;33:1315–1320.Google Scholar
3
3.Bath, PMW, Pathansali, R, Iddenden, R, Bath, FJ.The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis2001;11:265–272.CrossRefGoogle ScholarPubMed
4
4.Chein, Y, Piscataway, N.Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches. Am Heart J1984;108:207–216.CrossRefGoogle Scholar
5
5.Kanji, S, Corman, C, Douen, AG.Blood pressure management in acute stroke: comparison of current guidelines with prescribing patterns. Can J Neurol Sci2002;29:125–131.CrossRefGoogle ScholarPubMed
6
6.Rashid, P, Leonardi-Bee, JA, Weaver, CS, Bath, FJ, Bath, PMW.The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383 (abstract).Google Scholar
7
7.Bath, PM.Major ongoing stroke trials. Efficacy of Nitric Oxide in Stroke (ENOS) Trial. Stroke2001;32(10):2450–2451 (abstract).Google Scholar